7-83961457-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006080.3(SEMA3A):c.2230A>G(p.Ser744Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3A | NM_006080.3 | c.2230A>G | p.Ser744Gly | missense_variant | Exon 17 of 17 | ENST00000265362.9 | NP_006071.1 | |
SEMA3A | XM_005250110.4 | c.2230A>G | p.Ser744Gly | missense_variant | Exon 20 of 20 | XP_005250167.1 | ||
SEMA3A | XM_047419751.1 | c.2230A>G | p.Ser744Gly | missense_variant | Exon 21 of 21 | XP_047275707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3A | ENST00000265362.9 | c.2230A>G | p.Ser744Gly | missense_variant | Exon 17 of 17 | 1 | NM_006080.3 | ENSP00000265362.3 | ||
SEMA3A | ENST00000436949.5 | c.2230A>G | p.Ser744Gly | missense_variant | Exon 18 of 18 | 5 | ENSP00000415260.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251348Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135842
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461816Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727206
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2230A>G (p.S744G) alteration is located in exon 17 (coding exon 17) of the SEMA3A gene. This alteration results from a A to G substitution at nucleotide position 2230, causing the serine (S) at amino acid position 744 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
SEMA3A-related disorder Uncertain:1
The SEMA3A c.2230A>G variant is predicted to result in the amino acid substitution p.Ser744Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-83590773-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at